EMA committee recommends marketing approval of Pfizer & BioNTech's LP.8.1─adapted Covid─19 vaccine
Pfizer Inc. and BioNTech SE announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization for the companies’ LP.8.1-adapted monovalent Covid-19 vaccine (Comirnaty LP.8.1) …